[34] Growth hormone: In medicine, it is routinely used for the treatment of growth disorders in children, or in cases of proven clinical deficiency in adults
Tirzepatide is expected to show similar or better results, but until SURPASS-CVOT is completed, semaglutide maintains an advantage in this domain
Compounded preparations of AOD-9604 are not lawfully available in the United States as of the date of this listing, and the same restriction position applies under Health Canada's regulatory framework, where no authorized AOD-9604 product exists in any compounding category

Benefits AOD-9604 is believed to help with: Mechanistically designed to support fat breakdown and reduce new fat formation while having minimal direct impact on blood sugar and IGF1. May offer modest additional help with fat metabolism when combined with calorie control and exercise, particularly in higheradiposity individuals. Typically administered as a daily subcutaneous injection in low doses, integrated into a broader metabolic and lifestyle protocol. Longterm clinical safety data show generally good tolerability in studied populations, but regulators have highlighted unresolved immunogenicity and impurity concerns, so usage must remain cautious and fully consented. Positioned as an optional, supportive layernot a standalone weight-loss solutionwith emphasis on lab monitoring, habit coaching, and realistic expectations.
Reconstituting Selank involves mixing the lyophilized powder form of the peptide with a suitable solvent to prepare a solution for administration